Arca
Skip to content
Tools
Tools

Urothelial cancer

Drug research and approvals for urothelial cancer: what is recruiting, what Health Canada authorized, FDA orphan designations and EU medicines. See every condition.

As of Nov 22, 2026, 243 studies of urothelial cancer are recruiting on ClinicalTrials.gov, Health Canada has authorized 58 drug trials for it since 2013, and FDA has 1 approved and 2 open orphan designations naming it.

  • Recruiting worldwide: 243
  • Trials authorized in Canada: 58
  • FDA orphan approvals: 1
  • EU medicines: 0

Recruiting now

Newest posted first, of 243 recruiting on ClinicalTrials.gov ↗

Trials authorized in Canada

The 10 newest of 58; search them all in Canada trials
May 22, 2026A phase III, open-label, randomised, multicentre, global study of adjuvant datopotamab deruxtecan in combination with rilvegostomig in participants with…Datopotamab deruxtecan (dato-dxd, DS-1062A) / Rilvegostomig (AZD2936)AstraZeneca PharmaceuticalsOngoing
Feb 27, 2026A phase 3, randomized, open-label study of sacituzumab tirumotecan (MK-2870) carcinoma versus investigator’s choice of non-platinum chemotherapy in…Sacituzumab tirumotecan (MK-2870, SKB264)Merck & Co. (MSD)Ongoing
Dec 4, 2025Forager-2: a phase 3, randomized, double-blind, placebo-controlled study evaluating the efficacy and safety of vepugratinib combined with enfortumab vedotin…Vepugratinib (LY3866288) / Padcev (enfortumab vedotin) / Keytruda…Eli LillyPending
Sep 25, 2025A randomized, open-label, phase 2/3 study of datopotamab deruxtecan (DATODXD) plus carboplatin or cisplatin versus gemcitabine plus carboplatin or cisplatin in…Datopotamab deruxtecan (DS-1062A, dato-dxd) / Carboplatin injection / Cisplatin…Daiichi SankyoPending
Sep 23, 2025Izabright-bladder01: a randomized, open-label, phase 2/3 trial of izalontamab brengitecan versus platinum-based chemotherapy for metastatic urothelial cancer…BMS-986507 / Carboplatin bendalis / Ribozar / Cisplatin hikmaBristol-Myers SquibbOngoing
May 30, 2025A phase 1/2, single-arm, open-label trial to evaluate the safety and efficacy of nadofaragene firadenovec instilled to the renal pelvis in adult subjects with…AdstiladrinFerring PharmaceuticalsOngoing
Nov 7, 2024Modern: an integrated phase 2/3 and phase 3 trial of mrdbased optimization of adjuvant therapy in urothelial cancerOpdivo / BMS-986016Canadian Cancer Trials Group, Cancer Research Institute, Queen's UniversityOngoing
Jul 12, 2024Phase Ib trial of erdafitinib combined with enfortumab vedotin following platinum and PD1/L1 inhibitors for metastatic urothelial carcinoma with FGFR2/3…ErdafitinibUniversity Health NetworkClosed
Feb 21, 2024A randomized open-label phase 2/3 study of BT8009 as monotherapy or in combination in participants with locally advanced or metastatic urothelial cancer…Zelenectide pevedotin (BT8009) / Pembrolizumab / Carboplatin / Avelumab /…Bicycletx LimitedOngoing
Nov 6, 2023A phase 2/3 multicenter trial evaluating the safety and efficacy of ST-02 on ablation of urothelial carcinomas in the upper urinary tractGemcitabine (ST-02)Dr. Peter BlackOngoing

FDA orphan designations

Approved first, then open designations, newest first
Apr 15, 2020JelmytoJELMYTO® is indicated for the treatment of adult patients with low-grade Upper Tract Urothelial Cancer (LG-UTUC)UroGen Pharma, Ltd.Approved
Mar 2, 2021PadeliporfinTreatment of upper tract urothelial cancerSteba Biotech S.ADesignated
Dec 22, 2004PaclitaxelTreatment of non-superficial urothelial cancerSonus Pharmaceuticals, Inc.Designated

Condition names come from Health Canada's trial database. Orphan designations and EU medicines are matched when their indication names the condition as whole words, so a broader or differently worded indication can be missed. Recruiting counts are live from ClinicalTrials.gov's own condition search, refreshed daily. ClinicalTrials.gov, Health Canada Clinical Trials Database, FDA orphan designations, EMA

Esc

Type a name: a tool, a company, a drug or brand, a condition, a gene or a state. Identifiers like K231234, NCT05012345 or NDA 215866 open their record.

Logos are each company's own site icon, matched by name through Wikidata, or logos provided by Logo.dev.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.